Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 May;118(2):209–214. doi: 10.1111/j.1476-5381.1996.tb15388.x

An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret.

J A Rudd 1, R J Naylor 1
PMCID: PMC1909635  PMID: 8735616

Abstract

1. Cisplatin, 5 mg kg-1, i.p., administered as a single treatment, induced an acute (day 1) and delayed (days 2 and 3) emetic response in the ferret that was used to investigate the potential anti-emetic activity of ondansetron and dexamethasone and their interaction over a three day period. 2. Ondansetron, 1 mg kg-1, i.p., administered three times per day in two experiments, antagonized significantly the retching and vomiting that occurred on days 1 and 2 by 60-76 and 73-84%. On the third day of treatment there was a trend for a 38% reduction in one experiment and a 74% reduction in the other. 3. There was a trend for dexamethasone, 1 mg kg-1, i.p., administered as a single daily injection for three days, to reduce by 37% the retching and vomiting response that occurred on day 1, the reduction of 77% on day 2 achieved significance and dexamethasone non-significantly increased the retching and vomiting response by 46% on day 3. However, dexamethasone 1 mg kg-1 i.p. administered three times per day for three days significantly reduced the retching + vomiting response by 85, 97 and 86% on days 1, 2 and 3 respectively. 4. The combination of dexamethasone, 1 mg kg-1, i.p., as single daily injections with ondansetron, 1 mg kg-1, i.p., administered three times per day improved the control of the retching and vomiting response, significantly reducing the total numbers of retches and vomits by more than 70% over a three day period. The combination of dexamethasone (1.0 mg kg-1) and ondansetron (1.0 mg kg-1), both administered three times daily, abolished cisplatin-induced emesis over the three day period. 5. The three times per day administration of ondansetron, 1 mg kg-1, i.p., plus dexamethasone, 1 mg kg-1, i.p., administered only on day 1 prevented day 1 emesis but did not modify the retching and vomiting that occurred on days 2 and 3. 6. The present results indicate that ondansetron and dexamethasone significantly reduce cisplatin-induced emesis in the ferret during both the acute and delayed phase; drug/co-treatment can exert an additive action to abolish cisplatin-induced emesis. The ferret model may be useful to detect anti-emetic drug action for treatment of chemotherapy-induced acute and delayed emesis in man.

Full text

PDF
209

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews P. L., Rapeport W. G., Sanger G. J. Neuropharmacology of emesis induced by anti-cancer therapy. Trends Pharmacol Sci. 1988 Sep;9(9):334–341. doi: 10.1016/0165-6147(88)90106-x. [DOI] [PubMed] [Google Scholar]
  2. Baxendale B. R., Vater M., Lavery K. M. Dexamethasone reduces pain and swelling following extraction of third molar teeth. Anaesthesia. 1993 Nov;48(11):961–964. doi: 10.1111/j.1365-2044.1993.tb07474.x. [DOI] [PubMed] [Google Scholar]
  3. Bermudez J., Boyle E. A., Miner W. D., Sanger G. J. The anti-emetic potential of the 5-hydroxytryptamine3 receptor antagonist BRL 43694. Br J Cancer. 1988 Nov;58(5):644–650. doi: 10.1038/bjc.1988.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bishop J. F., Matthews J. P., Wolf M. M., Oliver I. N., Reynolds S., Walpole E., Rischin D., Buchanan L., Tan L. G. A randomised trial of dexamethasone, lorazepam and prochlorperazine for emesis in patients receiving chemotherapy. Eur J Cancer. 1992;28(1):47–50. doi: 10.1016/0959-8049(92)90382-c. [DOI] [PubMed] [Google Scholar]
  5. Cersosimo R. J., Karp D. D. Adrenal corticosteroids as antiemetics during cancer chemotherapy. Pharmacotherapy. 1986 May-Jun;6(3):118–127. doi: 10.1002/j.1875-9114.1986.tb03465.x. [DOI] [PubMed] [Google Scholar]
  6. Chalk J. B., Ridgeway K., Brophy T., Yelland J. D., Eadie M. J. Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients. J Neurol Neurosurg Psychiatry. 1984 Oct;47(10):1087–1090. doi: 10.1136/jnnp.47.10.1087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chevallier B., Marty M., Paillarse J. M. Methylprednisolone enhances the efficacy of ondansetron in acute and delayed cisplatin-induced emesis over at least three cycles. Ondansetron Study Group. Br J Cancer. 1994 Dec;70(6):1171–1175. doi: 10.1038/bjc.1994.467. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fredrikson M., Hursti T., Fürst C. J., Steineck G., Börjeson S., Wikblom M., Peterson C. Nausea in cancer chemotherapy is inversely related to urinary cortisol excretion. Br J Cancer. 1992 May;65(5):779–780. doi: 10.1038/bjc.1992.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gandara D. R., Harvey W. H., Monaghan G. G., Perez E. A., Hesketh P. J. Delayed emesis following high-dose cisplatin: a double-blind randomised comparative trial of ondansetron (GR 38032F) versus placebo. Eur J Cancer. 1993;29A Suppl 1:S35–S38. doi: 10.1016/s0959-8049(05)80259-x. [DOI] [PubMed] [Google Scholar]
  10. Hawthorn J., Cunningham D. Dexamethasone can potentiate the anti-emetic action of a 5HT3 receptor antagonist on cyclophosphamide induced vomiting in the ferret. Br J Cancer. 1990 Jan;61(1):56–60. doi: 10.1038/bjc.1990.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Higgins G. A., Kilpatrick G. J., Bunce K. T., Jones B. J., Tyers M. B. 5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret. Br J Pharmacol. 1989 May;97(1):247–255. doi: 10.1111/j.1476-5381.1989.tb11948.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hursti T. J., Fredrikson M., Steineck G., Börjeson S., Fürst C. J., Peterson C. Endogenous cortisol exerts antiemetic effect similar to that of exogenous corticosteroids. Br J Cancer. 1993 Jul;68(1):112–114. doi: 10.1038/bjc.1993.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kris M. G., Tyson L. B., Clark R. A., Gralla R. J. Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase II study and a review of completed trials to manage delayed emesis. Cancer. 1992 Aug 15;70(4 Suppl):1012–1016. [PubMed] [Google Scholar]
  14. Mataruski M. R., Keis N. A., Smouse D. J., Workman M. L. Effects of steroids on postoperative nausea and vomiting. Nurse Anesth. 1990 Dec;1(4):183–188. [PubMed] [Google Scholar]
  15. Roila F. Ondansetron plus dexamethasone compared to the 'standard' metoclopramide combination. Oncology. 1993 May-Jun;50(3):163–167. doi: 10.1159/000227171. [DOI] [PubMed] [Google Scholar]
  16. Rudd J. A., Bunce K. T., Naylor R. J. The interaction of dexamethasone with ondansetron on drug-induced emesis in the ferret. Neuropharmacology. 1996 Jan;35(1):91–97. doi: 10.1016/0028-3908(95)00137-9. [DOI] [PubMed] [Google Scholar]
  17. Rudd J. A., Naylor R. J. Effects of 5-HT3 receptor antagonists on models of acute and delayed emesis induced by cisplatin in the ferret. Neuropharmacology. 1994 Dec;33(12):1607–1608. doi: 10.1016/0028-3908(94)90136-8. [DOI] [PubMed] [Google Scholar]
  18. Ruff P., Paska W., Goedhals L., Pouillart P., Rivière A., Vorobiof D., Bloch B., Jones A., Martin C., Brunet R. Ondansetron compared with granisetron in the prophylaxis of cisplatin-induced acute emesis: a multicentre double-blind, randomised, parallel-group study. The Ondansetron and Granisetron Emesis Study Group. Oncology. 1994 Jan-Feb;51(1):113–118. doi: 10.1159/000227321. [DOI] [PubMed] [Google Scholar]
  19. Räth U., Upadhyaya B. K., Arechavala E., Böckmann H., Dearnaley D., Droz J. P., Fosså S. D., Henriksson R., Aulitzky W. E., Jones W. G. Role of ondansetron plus dexamethasone in fractionated chemotherapy. Oncology. 1993 May-Jun;50(3):168–172. doi: 10.1159/000227172. [DOI] [PubMed] [Google Scholar]
  20. Smith D. B., Newlands E. S., Rustin G. J., Begent R. H., Howells N., McQuade B., Bagshawe K. D. Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet. 1991 Aug 24;338(8765):487–490. doi: 10.1016/0140-6736(91)90555-4. [DOI] [PubMed] [Google Scholar]
  21. Tsuei S. E., Moore R. G., Ashley J. J., McBride W. G. Disposition of synethetic glucocorticoids. I. Pharmacokinetics of dexamethasone in healthy adults. J Pharmacokinet Biopharm. 1979 Jun;7(3):249–264. doi: 10.1007/BF01060016. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES